3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Prostatic Neoplasms
21
Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, Non-Hodgkin
8
Lymphoma, Follicular
7
Leukemia
6
Hodgkin Disease
6
Neoplasm Metastasis
5
Lymphoma, B-Cell
4
Burkitt Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell, Marginal Zone
3
Hemangioma
3
Recurrence
2
Neoplasms
2
Neoplasm, Residual
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Dendritic Cell Sarcoma, Interdigitating
2
Breast Neoplasms
2
Thymoma
1
Stomatitis
1
Prostate Cancer Metastatic
1
Philadelphia Chromosome
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Peripheral Blood Stem Cell Transplantation
32
fludarabine phosphate
29
Cyclophosphamide
26
Whole-Body Irradiation
21
Cyclosporine
20
Busulfan
20
Mycophenolic Acid
19
Tacrolimus
16
Antilymphocyte Serum
14
Methotrexate
13
romidepsin
12
Etoposide
12
Filgrastim
11
Melphalan
9
Psychiatric Rehabilitation
8
Methylprednisolone
8
Dexamethasone
8
Bexarotene
8
Vorinostat
7
Flow Cytometry
7
Therapeutics
6
Radiotherapy
6
Calcium Dobesilate
6
Brentuximab Vedotin
6
Bortezomib
6
Alemtuzumab
6
sargramostim
5
fludarabine
5
denileukin diftitox
5
Polymerase Chain Reaction
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoma, T-Cell, Cutaneous
×
Prednisolone
×
Clear all
NCT01198665
2015-03-03
RADCHOP
Samsung Medical Center
Phase 1/2
Completed
46 enrolled